DexCom
DXCM
DXCM
795 hedge funds and large institutions have $27.6B invested in DexCom in 2022 Q2 according to their latest regulatory filings, with 85 funds opening new positions, 313 increasing their positions, 300 reducing their positions, and 137 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
42% less capital invested
Capital invested by funds: $47.7B → $27.6B (-$20.1B)
47% less funds holding in top 10
Funds holding in top 10: 17 → 9 (-8)
294.86% less ownership
Funds ownership: 389.17% → 94.31% (-295%)
Holders
795
Holding in Top 10
9
Calls
$287M
Puts
$356M
Top Buyers
| 1 | +$166M | |
| 2 | +$145M | |
| 3 | +$123M | |
| 4 |
Sands Capital Management
Arlington,
Virginia
|
+$105M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$88.3M |
Top Sellers
| 1 | -$437M | |
| 2 | -$263M | |
| 3 | -$168M | |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
-$135M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$119M |